Physician

Michael Robert Nuyles, D.O.

According to 2025 Medicare claims, Michael Nuyles, D.O. (NPI: 1003055179) practices interventional cardiology in the Elgin, IL market, with the plurality of this provider's patient population coming from Kane, IL. This provider's primary affiliated billing organization is ADVOCATE HEALTH AND HOSPITALS CORPORATION (NPI: 1003542184; TIN: 362169147) and primary practice location at 60542-5142. Nuyles is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033) and Accountable Care Organization of Advocate Aurora Health, LLC (ACO ID: D0260), participating under both the MSSP and REACH models.

Nuyles' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,506 traditional Medicare patients, billed 4,303 HCPCS/CPT codes, and received $305,262 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,994 prescription claims across 780 beneficiaries totaling $1,110,098 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 22 claims. Open Payments data shows 37 records totaling $1,058. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $255,003 to $305,262. In contrast, Part D prescription costs have moved sharply higher in recent years, from $139,398 to $1,110,098. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $66,864 and ending at $27,989.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,248	4,904	$255,003
2016	1,164	4,713	$615,251
2017	1,024	4,270	$514,616
2018	1,005	4,612	$544,128
2019	1,144	3,769	$565,974
2020	1,161	3,724	$543,535
2021	941	3,172	$517,256
2022	738	2,013	$226,551
2023	1,313	4,004	$278,531
2024	1,506	4,303	$305,262

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	345	1,900	$139,398
2016	462	3,391	$204,350
2017	458	3,412	$246,577
2018	511	3,519	$284,400
2019	547	3,703	$371,048
2020	599	4,427	$470,969
2021	624	4,777	$483,503
2022	633	5,043	$604,431
2023	717	5,590	$911,764
2024	780	6,994	$1,110,098

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	32	$66,838
2016	N/R	11	$21,151
2017	N/R	23	$48,211
2018	N/R	N/R	N/R
2019	24	24	$16,963
2020	22	22	$15,716
2021	22	22	$15,928
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	475	631	$94
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	93	100	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	509	727	$11
36415	Insertion of needle into vein for collection of blood sample	153	243	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	753	1,203	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	311	20,727	$399,282
Xarelto	Rivaroxaban	152	11,076	$201,694
Brilinta	Ticagrelor	125	8,060	$117,427
Entresto	Sacubitril/Valsartan	86	5,100	$105,992
Jardiance	Empagliflozin	70	4,770	$92,994

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	37	$1,058	AngioDynamics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Robert Nuyles, D.O.?

Tedicare shows public-source Medicare data for Michael Robert Nuyles, D.O. (NPI 1003055179), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Robert Nuyles, D.O. have ACO affiliation data?

Michael Robert Nuyles, D.O. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033) and Accountable Care Organization of Advocate Aurora Health, LLC (REACH, ACO ID D0260).

What billing organization is linked to Michael Robert Nuyles, D.O.?

Michael Robert Nuyles, D.O. is linked to ADVOCATE HEALTH AND HOSPITALS CORPORATION (billing NPI 1003542184) in the available physician profile data.

Does Michael Robert Nuyles, D.O. have Open Payments data?

Michael Robert Nuyles, D.O. has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.